Infinity Bio, Inc.

Infinity Bio, Inc.

Biotechnology Research

Baltimore, Maryland 519 followers

The Antibody Reactome Profiling Company - Characterizing the Reactivities of Individuals' Antibody Repertoire

About us

Infinity Bio is a technology company that provides detailed insights into the immune system using its proprietary antibody profiling platform. The company’s core technology comprehensively measures the antibody reactome, revealing the targets of individual immune responses against all known human viruses, human proteins (autoimmunity), and allergen proteins. Infinity's assay, MIPSA, was developed at Johns Hopkins University in Ben Larman's Lab of Precision Immunology. It builds off decades of work in the fields of genomics, proteomics, immunology, and bioinformatics. Our assay was engineered to enable best-in-class turnaround times and cost. With a team of experienced professionals and a state-of-the-art facility, we are poised to make a significant impact to research and for our customers.

Website
www.infinitybio.com
Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Baltimore, Maryland
Type
Privately Held
Founded
2023
Specialties
Antibody , Immunology, Biotechnology, Services, Viruses, Allergens, Peptides, Proteomics, Autoimmune, Infectious Diseases, and Vaccines

Locations

Employees at Infinity Bio, Inc.

Updates

Similar pages